All News

Tranexamic acid can safely be used in all trauma patients, not just those who are the most severely injured, according to data analyses results published in the Sept. 11 issue of the British Medical Journal.

A group of 45 pharmacies in southern Texas are doing their best to get their patients registered, and ready to vote Nov. 6 in the hopes that the state will pay more attention to the struggling pharmacies in the four-county area.

As the number of cases and deaths associated with the national meningitis outbreak continues to rise, one has to ask the question, could this public health disaster been averted?

The National Association of Specialty Pharmacy (NASP), a new organization that focuses on specialty pharmacy, had its first event this week at the Academy of Managed Care Pharmacy Educational Conference in Cincinnati, Ohio, and it announced Michael A. Nameth, RPh, MBA, will serve as the interim executive director.

The U.S. Pharmacopeial Convention (USP) is in the process of changing the look and format of prescription labels to make them easier for patients to understand.

After reviewing new data, FDA has concluded that Budeprion XL 300 mg (bupropion hydrochloride extended-release tablets), manufactured by Impax Laboratories, Inc., and marketed by Teva Pharmaceuticals USA, Inc., is not therapeutically equivalent to GlaxoSmithKline’s Wellbutrin XL 300 mg.

An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law.

FDA has approved Boston Therapeutic’s petition to file an Abbreviated New Drug Application (ANDA) for a new, chewable tablet formulation of the diabetes drug metformin hydrochloride. The company plans to market the new formulation under the name Pazamet.

Metformin is a safe and effective drug for the treatment of type 2 diabetes and can be used in patients with varying degrees of renal impairment, according to a long-term observational study that was published online in the British Medical Journal.

The Centers for Disease Control and Prevention (CDC) and the FDA are jointly investigating a meningitis outbreak that has affected approximately 35 people in six states so far. Five patients have died and 30 are ill after receiving an epidural steroid injection contaminated by fungus, according to a report issued from CDC yesterday.

Abbott Laboratories Inc. was sentenced Oct. 2 to pay a total of $700 million after pleading guilty in May to misbranding divalproex (Depakote), a criminal misdemeanor.

Biologic response modifiers developed for the treatment of rheumatoid arthritis do not appear to be associated with an increased risk of cancer, according to a study published September 5 in the Journal of the American Medical Association.

Children with asthma who use glucocorticoid inhalers may grow shorter on average than those who do not use inhaled corticosteroids (ICS), according to a study published September 6 in the New England Journal of Medicine.

FDA has granted delafloxacin (Rib-X) as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

While beta-blocker use continues to be the standard of care for patients with coronary artery disease (CAD), especially for those patients who have had a myocardial infarction (MI), these drugs may not be effective long term, according to an online report published Oct. 3 in JAMA.

Apixaban (Eliquis), an investigational anticoagulant developed by Bristol-Myers Squibb and Pfizer, has lower rates of stroke, systemic embolism, and bleeding than warfarin in patients with atrial fibrillation, regardless of level of risk for these events, according a recent online analysis published October 2 in The Lancet.

The Cystic Fibrosis Foundation (CFF) is teaming up with Walgreens to better serve patient with cystic fibrosis (CF).

The level of satisfaction reported by customers who use community pharmacies is higher than the satisfaction of customers who use mail order, according to a recent JD Power and Associates 2012 U.S. Pharmacy Study.

The acellular pertussis vaccine that was introduced in the 1990s may not offer long-lasting protection against whooping cough in immunized children after the fifth dose, according to a case-control study published September 13 in the New England Journal of Medicine.

The National Association of Chain Drug Stores (NACDS) Foundation is providing 15 additional academic institutions with educational grants for the Community Pharmacy Residency Expansion Project (Community PREP).

The National Association of Chain Drug Stores (NACDS) is urging pharmacists to get involved in the Nov. 6 presidential election.

Long-term users of methamphetamine compared with heroin users in an urban setting had a high prevalence of dental disease, much higher than the general U.S. population, according to a small cross-sectional study published September 1 in the Journal of the American Dental Association.

Knowledge is power. In case you haven't looked at your company's P&P manual lately, contributor Steve Ariens takes you straight to a very basic reason for staying informed.

October marks the beginning of American Pharmacists Month, and the American Pharmacists Association (APhA) is urging pharmacists to build relationships with their patients.

Janssen Pharmaceuticals, Inc. is making it easier for pharmacists and healthcare professionals to look up drug information by launching an online scientific resource tool.

Thirteen New York City public high school nurses are taking on the role of the pharmacist by dispensing emergency contraceptive pills to hundreds of students, according to a Reuters report.

A new survey of retail pharmacists revealed that cost remains a key barrier to medication adherence, with approximately one-third of patients deciding not to fill a prescription at least once.

The National Association of Chain Drug Stores (NACDS) is urging pharmacists to get involved in the Nov. 6 presidential election.